- Home
- PALI vs OPRX Comparison
PALI vs OPRX Comparison
Compare PALI & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PALI | OPRX |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.2M | 222.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PALI | OPRX |
|---|---|---|
| Price | $1.73 | $8.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $15.00 | ★ $19.67 |
| AVG Volume (30 Days) | ★ 4.6M | 386.9K |
| Earning Date | 03-23-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | N/A | ★ $109,506,000.00 |
| Revenue This Year | N/A | $19.77 |
| Revenue Next Year | N/A | $11.33 |
| P/E Ratio | ★ N/A | $4,797.23 |
| Revenue Growth | N/A | ★ 24.18 |
| 52 Week Low | $0.53 | $3.99 |
| 52 Week High | $2.64 | $22.25 |
Technical Indicators
Market Signals| Indicator | PALI | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.72 | 24.50 |
| Support Level | $1.65 | $7.80 |
| Resistance Level | $1.84 | $11.91 |
| Average True Range (ATR) | 0.13 | 0.93 |
| MACD | 0.02 | -0.22 |
| Stochastic Oscillator | 77.50 | 8.33 |
Price Performance
Historical ComparisonAbout PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.